Comparison results
| Results: Differences General | ✘C52 | ✘C77.8 | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 38% | 32% | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | 23% | 58% | |||||||||||||
| dubreuil 's melanosis | 36% | 30% | |||||||||||||
| роды и вскармливание | 6% | 6% | |||||||||||||
| nodular melanoma | 38% | 32% | |||||||||||||
| lentigo | 34% | 29% | |||||||||||||
| melanoma | 32% | 27% | |||||||||||||
| lot of moles | 30% | 25% | |||||||||||||
| choroid melanoma | 24% | 20% | |||||||||||||
| benign neoplasms | 22% | 18% | |||||||||||||
| brown spots on the skin | 22% | 18% | |||||||||||||
| lymphadenitis | 23% | 19% | |||||||||||||
| dysplastic nevus | 23% | 19% | |||||||||||||
| suspicion | 23% | 19% | |||||||||||||
| oncology in the anamnesis | 24% | 20% | |||||||||||||
| melanoma of the eye | 24% | 20% | |||||||||||||
| brown moles | 26% | 22% | |||||||||||||
| metastases | 24% | 20% | |||||||||||||
| subarticular melanoma | 24% | 20% | |||||||||||||
| sunburn | 25% | 21% | |||||||||||||
| nevus spitz | 26% | 22% | |||||||||||||
| skin cancer | 26% | 22% | |||||||||||||
| moles appear | 27% | 23% | |||||||||||||
| solid tumors | 28% | 24% | |||||||||||||
| hyperpigmentation | 28% | 24% | |||||||||||||
| breast cancer | 28% | 24% | |||||||||||||
| increased bleeding | 21% | 17% | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
